期刊文献+

加味玉屏风散治疗儿童哮喘缓解期25例 被引量:8

25 cases of pediatric remission stage asthma treated with increased Yupingfeng Powder
下载PDF
导出
摘要 目的:观察加味玉屏风散治疗儿童哮喘缓解期的疗效。方法:将50例哮喘缓解期儿童按随机数字表法分为治疗组和对照组各25例,治疗组给予加味玉屏风散口服,对照组给予布地奈德气雾剂吸入,2组均治疗3月,随访1年。结果:治疗组总有效率92%,对照组总有效率72%,治疗组疗效优于对照组(P<0.05);2组治疗后随访1年内哮喘发作次数分别为:治疗组(1.8±1.4)次,对照组(3.6±1.2)次,2组比较差异有统计意义(P<0.05)。结论:加味玉屏风散治疗儿童哮喘缓解期,可显著改善哮喘症状,明显减少哮喘反复发作的次数,提高哮喘患儿生活质量,安全简便,值得临床推广应用。 Objective: To observe the effect of increased Yupingfeng Powder to pediatric remission stage asthma.Methods: Randomly put 50 cases of remission stage asthma patient into treatment group and control group,25 cases for each group,treatment group were treated with increased Yupingfeng Powder,while the control group were treated with Budesonide aerosol inhalation.The two groups were all treated for 3 months,followed up for 1 year.Results: The total effective rate for treatment group was 92%,for control group was 72%,the effects in the treatment group was superior to the control group(P0.05);the recurrent times of the groups in the 1 year following-up period was(1.8±1.4) for treatment group,(3.6±1.2) for control group.The difference had statistical significance(P0.05).Conclusion: In the treatment of pediatric remission stage asthma,increased Yupingfeng Powder can obviously improve the symptom,reduce the recurrent times,greatly raise the life quality,which is safe and simple,deserves to be wide spread.
作者 康立媛
出处 《中医儿科杂志》 2012年第3期23-25,共3页 Journal of Pediatrics of Traditional Chinese Medicine
关键词 儿童哮喘缓解期 加味玉屏风散 疗效观察 pediatric remission stage asthma increased Yupingfeng Powder clinical effect observation
  • 相关文献

参考文献12

二级参考文献34

  • 1鲍一笑,王永午,叶曜芩.T淋巴细胞在支气管哮喘中的作用[J].国外医学(呼吸系统分册),1993,13(2):79-80. 被引量:26
  • 2傅祖红,邢祖林.支气管哮喘患者CD^(23)表达与体外调控的研究[J].中华内科杂志,1996,35(4):228-230. 被引量:2
  • 3陈育智 华云汉.儿童哮喘诊断治疗常规[J].中华结核和呼吸杂志,1993,16:10-10.
  • 4中华中医药学会.中医体质分类与判定[M].北京:中国中医药出版社,2009:26.
  • 5Centers for disease control and prevention. Asthma mortality and hospitalization among children and young adults - uniled states, 1980 - 1993 [ J]. Morp Mortal wkly Rep, 1996, 45 : 350.
  • 6Fahy Jr, Boushey HA. Controversies involving inhaled beta - agonist and inhaled eortie osteroids in the treatment of asthma [J]. Clin Chest Med, 1995, 16 (4): 715.
  • 7Matsumoto K,Taki F, Miura M, et al. Serum levels of soluble IL-2R, IL-4 and soluble Fc epsilon R Ⅱ in adult bronchial asthma[J].Chest, 1994,105 (3) : 681 - 686.
  • 8Gagro A, Rabatic S, Trescec A, et al. Expression of lymphocytes Fc epsilon RⅡ/CD23 in allergic children undergoing hyposen sitization[J]. kit Arch Allergy Immunol, 1993,101 (2) : 203-208.
  • 9Hallstrand T, Auh K, Bates P, et al. Peripheral blood manifestations of Th2 lymphocyte activation in stable atopic asthma and during exercise- induced bronchospasm[J]. Ann Allergy Asthma Immunol, 1998,80( 5 ) : 424 -- 432.
  • 10Hakansson L, Heinrich C, Rak S, et al. Activation of B-lymphocytes during pollen season. Effect of immunotherapy[J]. Clin Exp Allergy, 1998,28(7) : 791-798.

共引文献3367

同被引文献135

引证文献8

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部